This site is intended for healthcare professionals

CHMP grants positive opinion for Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination With Kalydeco (ivacaftor) in people ages 12 and older With Cystic Fibrosis with the most common genotypes.- Vertex

Read time: 1 mins
Last updated:29th Jun 2020
Published:27th Jun 2020
Condition: Cystic Fibrosis-F508del-gene
Type: drug
Register free for full access to